Thiocolchicine
Thiocolchicine is a potent tubulin polymerization inhibitor (IC50=2.5 μM, Ki=0.7 μM) that induces apoptotic cell death. It serves as a cytotoxic payload in Antibody-Drug Conjugate (ADC) development and is used in cancer research for both in vitro mechanistic studies and in vivo efficacy models.
Product Specifications
CAS Number
2730-71-4
Product Name Alternative
Tubulin polymerization, Thiocolchicine, Inhibitor, MDR-positive, MCF-7, leukemia, inhibit, LoVo, LoVo/DX, Microtubule/Tubulin, Microtubule Associated, MicrotubuleAssociated, Apoptosis, Analogue, cancer, BALB/3T3, A-549, breast, Colchicine
Field of Research
Cell Biology, Signal Transduction
Purity
98.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.94 mM) ; DMSO:95 mg/mL (228.64 mM)
Smiles
COc1cc2CC[C@H] (NC (C) =O) c3cc (=O) c (SC) ccc3-c2c (OC) c1OC
Molecular Formula
C22H25NO5S
Molecular Weight
415.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS636259-01 0.05 mg
APOBEC3G, Recombinant, Human (CEM15, Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G)
Sign In for Pricing
View Details MBS636259-02 5x 0.05 mg
APOBEC3G, Recombinant, Human (CEM15, Apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G)
Sign In for Pricing
View Details 
C2432-01EX 100 µg
CD80 (T-lymphocyte Activation Antigen CD80, Activation B7-1 Antigen, B7, B7.1, B7-1, BB1, CD28LG, CD28LG1, CTLA-4 Counter-receptor B7.1, LAB7)
Sign In for Pricing
View Details